S19-458 Biomarkers Predict Response to HER2-Targeted Breast Cancer Therapies Researchers at Stanford have leveraged spatial proteomic analysis to identify biomarkers with immediate implications for HER2-positive breast cancer treatment decision making and patient stratification. Christina Curtis Katherine Pogrebniak